van Megen HJ - Search Results

1

Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine.

Ho Pian KL, van Megen HJ, Ramsey NF, Mandl R, van Rijk PP, Wynne HJ, Westenberg HG. Ho Pian KL, et al. Among authors: van megen hj, van rijk pp. Psychiatry Res. 2005 Feb 28;138(2):89-97. doi: 10.1016/j.pscychresns.2004.12.003. Psychiatry Res. 2005. PMID: 15766633

2

d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder.

de Leeuw AS, van Megen HJ, Kahn RS, Westenberg HG. de Leeuw AS, et al. Among authors: van megen hj. Eur Psychiatry. 2017 Feb;40:38-44. doi: 10.1016/j.eurpsy.2016.06.011. Epub 2016 Nov 10. Eur Psychiatry. 2017. PMID: 27837671 Clinical Trial.

3

Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT.

van der Wee NJ, Stevens H, Hardeman JA, Mandl RC, Denys DA, van Megen HJ, Kahn RS, Westenberg HM. van der Wee NJ, et al. Among authors: van megen hj. Am J Psychiatry. 2004 Dec;161(12):2201-6. doi: 10.1176/appi.ajp.161.12.2201. Am J Psychiatry. 2004. PMID: 15569890

4

Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care.

Denys D, van Megen HJ, Westenberg HG. Denys D, et al. Among authors: van megen hj. J Psychopharmacol. 2003 Mar;17(1):127-9. doi: 10.1177/0269881103017001718. J Psychopharmacol. 2003. PMID: 12680750

5

A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.

Denys D, van der Wee N, van Megen HJ, Westenberg HG. Denys D, et al. Among authors: van megen hj, van der wee n. J Clin Psychopharmacol. 2003 Dec;23(6):568-75. doi: 10.1097/01.jcp.0000095342.32154.54. J Clin Psychopharmacol. 2003. PMID: 14624187 Clinical Trial.

6

A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.

Denys D, van Megen HJ, van der Wee N, Westenberg HG. Denys D, et al. Among authors: van megen hj, van der wee n. J Clin Psychiatry. 2004 Jan;65(1):37-43. doi: 10.4088/jcp.v65n0106. J Clin Psychiatry. 2004. PMID: 14744166 Clinical Trial.

7

A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.

Denys D, de Geus F, van Megen HJ, Westenberg HG. Denys D, et al. Among authors: van megen hj. J Clin Psychiatry. 2004 Aug;65(8):1040-8. doi: 10.4088/jcp.v65n0803. J Clin Psychiatry. 2004. PMID: 15323587 Clinical Trial.

8

Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder.

Denys D, de Geus F, van Megen HJ, Westenberg HG. Denys D, et al. Among authors: van megen hj. Psychiatry Res. 2004 Oct 30;128(3):273-80. doi: 10.1016/j.psychres.2003.11.005. Psychiatry Res. 2004. PMID: 15541785

9

Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.

Tenneij NH, van Megen HJ, Denys DA, Westenberg HG. Tenneij NH, et al. Among authors: van megen hj. J Clin Psychiatry. 2005 Sep;66(9):1169-75. doi: 10.4088/jcp.v66n0913. J Clin Psychiatry. 2005. PMID: 16187776 Clinical Trial.

10

Spatial working memory in obsessive-compulsive disorder improves with clinical response: A functional MRI study.

van der Wee NJ, Ramsey NF, van Megen HJ, Denys D, Westenberg HG, Kahn RS. van der Wee NJ, et al. Among authors: van megen hj. Eur Neuropsychopharmacol. 2007 Jan;17(1):16-23. doi: 10.1016/j.euroneuro.2006.04.012. Epub 2006 Jun 21. Eur Neuropsychopharmacol. 2007. PMID: 16797166 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters